Aoife Commins shares her story of being diagnosed with HIV after her health slowly started deteriorating to the point it was ...

Zoliflodacin and gepotidacin make oral therapy viable again for urogenital gonorrhea, yet lower pharyngeal efficacy and weak resistance surveillance mean clinicians must adopt cautious, targeted use.

So, people came up with all manner of preposterous treatment to ‘save’ desperate people. I remember there was a soup of dog heads. Nanyonga’s was from a divine dream that directed her to the ‘white ...

Experts are calling for more community involvement to fight against the scourge of tuberculosis (TB) in South Africa. March marks TB Awareness month under the theme, “Yes! We Can End TB! Led by ...

Africa carries a disproportionate share of the global hepatitis B virus (HBV) burden.1 An estimated 64·7 million people in Africa are living with chronic HBV infection—a condition associated with high ...

Commercialization ready compound supports a new method of generating highly functional human CAR-T cells for treating infectious diseases and cancer In experimental models, human CAR-T cells ...

Latent HIV-1 reservoirs are a major barrier to curing HIV because the virus can hide silently inside cells for years. In a laboratory model of HIV ...

A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells ...

The MarketWatch News Department was not involved in the creation of this content. Strategy May Bolster Blood Cancer Therapy and Move HIV Research Closer to a Cure BRONX, N.Y., March 13, 2026 ...

The approach relies on a specially engineered scaffold that links three naturally occurring cytokines known to promote immune memory.

A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells that dramatically prolongs their effectiveness after being infused into ...

US-supported international HIV research, particularly that conducted in African countries, has direct benefits to Americans. Cuts to that research may undermine those benefits.